Search research articles
Contact Us
Filters
Showing results (31-40 of 117) with videos related to
Page
of 12
Sort By:
Current Medical Research and Opinion
|
January 20, 2017
Brexit and rare diseases: big risk, bigger opportunity?
Hanna I Hyry, Timothy M Cox, Jonathan C P Roos
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 16, 2016
Saving orphan drug legislations: misconceptions and clarifications
Hanna I Hyry, Timothy M Cox, Jonathan C P Roos
Frontiers in Pharmacology
|
October 17, 2022
Editorial: Prevention, diagnosis and treatment of rare disorders
Timothy M Cox, Anna Tylki-Szymańska, Ségolène Aymé, et al.
Clinical Medicine (London, England)
|
January 25, 2013
The Cambridge Bachelor of Medicine (MB)/Doctor of Philosophy (PhD): graduate outcomes of the first MB/PhD programme in the UK
Timothy M Cox, James Brimicombe, Diana F Wood, et al.
The Journal of Pathology
|
October 6, 2017
Reduced cerebral vascularization in experimental neuronopathic Gaucher disease
Nicholas Jc Smith, Maria Fuller, Jennifer T Saville, et al.
Expert Opinion on Therapeutic Targets
|
November 23, 2014
Emerging therapeutic targets for Gaucher disease
Einat B Vitner, Ayelet Vardi, Timothy M Cox, et al.
Orphanet Journal of Rare Diseases
|
August 22, 2015
Compassionate use of orphan drugs
Hanna I Hyry, Jeremy Manuel, Timothy M Cox, et al.
Human Molecular Genetics
|
December 15, 2022
Upregulation of non-canonical and canonical inflammasome genes associates with pathological features in Krabbe disease and related disorders
María B Cachón-González, Chao Zhao, Robin J Franklin, et al.
Orphanet Journal of Rare Diseases
|
September 10, 2013
The legal imperative for treating rare disorders
Hanna I Hyry, Jonathan C P Roos, Jeremy Manuel, et al.
Neurobiology of Disease
|
May 19, 2009
Critical role of iron in the pathogenesis of the murine gangliosidoses
Mylvaganam Jeyakumar, Ian Williams, David Smith, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 117) with videos related to
Sort By:
Page
of 12
Current Medical Research and Opinion
|
January 20, 2017
Brexit and rare diseases: big risk, bigger opportunity?
Hanna I Hyry, Timothy M Cox, Jonathan C P Roos
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 16, 2016
Saving orphan drug legislations: misconceptions and clarifications
Hanna I Hyry, Timothy M Cox, Jonathan C P Roos
Frontiers in Pharmacology
|
October 17, 2022
Editorial: Prevention, diagnosis and treatment of rare disorders
Timothy M Cox, Anna Tylki-Szymańska, Ségolène Aymé, et al.
Clinical Medicine (London, England)
|
January 25, 2013
The Cambridge Bachelor of Medicine (MB)/Doctor of Philosophy (PhD): graduate outcomes of the first MB/PhD programme in the UK
Timothy M Cox, James Brimicombe, Diana F Wood, et al.
The Journal of Pathology
|
October 6, 2017
Reduced cerebral vascularization in experimental neuronopathic Gaucher disease
Nicholas Jc Smith, Maria Fuller, Jennifer T Saville, et al.
Expert Opinion on Therapeutic Targets
|
November 23, 2014
Emerging therapeutic targets for Gaucher disease
Einat B Vitner, Ayelet Vardi, Timothy M Cox, et al.
Orphanet Journal of Rare Diseases
|
August 22, 2015
Compassionate use of orphan drugs
Hanna I Hyry, Jeremy Manuel, Timothy M Cox, et al.
Human Molecular Genetics
|
December 15, 2022
Upregulation of non-canonical and canonical inflammasome genes associates with pathological features in Krabbe disease and related disorders
María B Cachón-González, Chao Zhao, Robin J Franklin, et al.
Orphanet Journal of Rare Diseases
|
September 10, 2013
The legal imperative for treating rare disorders
Hanna I Hyry, Jonathan C P Roos, Jeremy Manuel, et al.
Neurobiology of Disease
|
May 19, 2009
Critical role of iron in the pathogenesis of the murine gangliosidoses
Mylvaganam Jeyakumar, Ian Williams, David Smith, et al.
Page
of 12